Table 2.
No. | PET/CT findings | SUV max | Pathology of resected GC | Interval time |
1 | Retroperitoneal lymph nodes | 6.0 | MPD tubular adeno ca and mucinous adeno Ca | 12 mo |
2 | Retroperitoneal lymph nodes | 5.2 | PD adeno ca and signet-ring cell Ca | 3 mo |
Supraclavicular lymph nodes | 6.6 | |||
Osseous metastasis | 3.8 | |||
3 | Esophageal carcinoma | 14.2 | MPD adeno Ca | 10 yr |
4 | Anastomosis recurrence with pancreas involvement | 5.6 | PD adeno Ca | 5 mo |
5 | Osseous metastasis | 2.5 | MPD adeno Ca | 25 mo |
6 | Liver metastasis | 7.2 | MPD signet-ring cell Ca | 15 mo |
7 | Greater omentum lymph nodes | 1.3 | PD signet-ring cell Ca | 8 mo |
8 | Abdominal wall metastasis | 2.5 | PD signet-ring cell Ca | 24 mo |
Ovarian metastasis | ||||
9 | Liver metastasis | 5.3 | PD adenosquamous Ca | 3 mo |
Intraperitoneal lymph nodes | 17.6 | |||
10 | Abdominal wall metastasis | 3.2 | MPD adeno Ca | 24 mo |
11 | Intraperitoneal lymph nodes | 7.7 | MPD adeno Ca | 36 mo |
12 | Brain metastasis | 8.1 | PD adeno Ca | 6 mo |
13 | Osseous metastasis | 12.6 | MPD adeno Ca | 20 mo |
Retroperitoneal lymph nodes | 7.0 | |||
14 | Anastomosis recurrence | 4.3 | MPD adeno Ca | 5 mo |
MPD: Moderately to poorly differentiated; PD: Poorly differentiated; GC: Gastric cancer; Interval time: Time period from operation to PET/CT scan; Ca: Carcinoma.